These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 18006700

  • 1. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency.
    Józsi M, Licht C, Strobel S, Zipfel SL, Richter H, Heinen S, Zipfel PF, Skerka C.
    Blood; 2008 Feb 01; 111(3):1512-4. PubMed ID: 18006700
    [Abstract] [Full Text] [Related]

  • 2. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.
    Lee BH, Kwak SH, Shin JI, Lee SH, Choi HJ, Kang HG, Ha IS, Lee JS, Dragon-Durey MA, Choi Y, Cheong HI.
    Pediatr Res; 2009 Sep 01; 66(3):336-40. PubMed ID: 19531976
    [Abstract] [Full Text] [Related]

  • 3. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.
    Moore I, Strain L, Pappworth I, Kavanagh D, Barlow PN, Herbert AP, Schmidt CQ, Staniforth SJ, Holmes LV, Ward R, Morgan L, Goodship TH, Marchbank KJ.
    Blood; 2010 Jan 14; 115(2):379-87. PubMed ID: 19861685
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome.
    Zipfel PF, Edey M, Heinen S, Józsi M, Richter H, Misselwitz J, Hoppe B, Routledge D, Strain L, Hughes AE, Goodship JA, Licht C, Goodship TH, Skerka C.
    PLoS Genet; 2007 Mar 16; 3(3):e41. PubMed ID: 17367211
    [Abstract] [Full Text] [Related]

  • 9. The autoimmune disease DEAP-hemolytic uremic syndrome.
    Skerka C, Zipfel PF, Müller D, Micklisch S, Riedl M, Zimmerhackl LB, Hofer J.
    Semin Thromb Hemost; 2010 Sep 16; 36(6):625-32. PubMed ID: 20865639
    [Abstract] [Full Text] [Related]

  • 10. DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome.
    Zipfel PF, Mache C, Müller D, Licht C, Wigger M, Skerka C, European DEAP-HUS Study Group.
    Pediatr Nephrol; 2010 Oct 16; 25(10):2009-19. PubMed ID: 20157737
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Successful treatment of DEAP-HUS with eculizumab.
    Noone D, Waters A, Pluthero FG, Geary DF, Kirschfink M, Zipfel PF, Licht C.
    Pediatr Nephrol; 2014 May 16; 29(5):841-51. PubMed ID: 24249282
    [Abstract] [Full Text] [Related]

  • 16. The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease.
    Bhattacharjee A, Reuter S, Trojnár E, Kolodziejczyk R, Seeberger H, Hyvärinen S, Uzonyi B, Szilágyi Á, Prohászka Z, Goldman A, Józsi M, Jokiranta TS.
    J Biol Chem; 2015 Apr 10; 290(15):9500-10. PubMed ID: 25659429
    [Abstract] [Full Text] [Related]

  • 17. Atypical hemolytic uremic syndrome-associated variants and autoantibodies impair binding of factor h and factor h-related protein 1 to pentraxin 3.
    Kopp A, Strobel S, Tortajada A, Rodríguez de Córdoba S, Sánchez-Corral P, Prohászka Z, López-Trascasa M, Józsi M.
    J Immunol; 2012 Aug 15; 189(4):1858-67. PubMed ID: 22786770
    [Abstract] [Full Text] [Related]

  • 18. Case report: A family of atypical hemolytic uremic syndrome involving a CFH::CFHR1 fusion gene and CFHR3-1-4-2 gene duplication.
    Tasaki Y, Tsujimoto H, Yokoyama T, Sugimoto N, Kitajima S, Fujii H, Hidaka Y, Kato N, Maruyama S, Inoue N, Wada T.
    Front Immunol; 2024 Aug 15; 15():1360855. PubMed ID: 38524137
    [Abstract] [Full Text] [Related]

  • 19. Factor H-related protein 1 neutralizes anti-factor H autoantibodies in autoimmune hemolytic uremic syndrome.
    Strobel S, Abarrategui-Garrido C, Fariza-Requejo E, Seeberger H, Sánchez-Corral P, Józsi M.
    Kidney Int; 2011 Aug 15; 80(4):397-404. PubMed ID: 21677636
    [Abstract] [Full Text] [Related]

  • 20. Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1/CFHR3 gene mutation-associated HUS.
    Grenda R, Jarmużek W, Rubik J, Prokurat S, Miklaszewska M, Drozdz D, Zachwieja K, Ardissino G, Hofer J.
    Pediatr Transplant; 2015 Sep 15; 19(6):E130-4. PubMed ID: 26087050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.